NFKB1 and glioblastoma: Several other genes associated with NF-κB signaling were present in the significant results for typical responders, including IL6, BCL3, and TRIB2. Activation of NF-κB in GBM has been shown to contribute to angiogenesis and temozolomide resistance [29].